You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 4, July 28, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Pregnancy and Breast Feeding
 •Diagnosis
 •Pathology & Laboratory Medicine
 •Alert me on articles by topic

Diagnosis of Intra-amniotic Infection by Proteomic Profiling and Identification of Novel Biomarkers

Michael G. Gravett, MD; Miles J. Novy, MD; Ron G. Rosenfeld, MD; Ashok P. Reddy, PhD; Thomas Jacob, PhD; Mark Turner, MS; Ashley McCormack, PhD; Jodi A. Lapidus, PhD; Jane Hitti, MD; David A. Eschenbach, MD; Charles T. Roberts, Jr, PhD; Srinivasa R. Nagalla, MD

JAMA. 2004;292:462-469.

Context  Intra-amniotic infection (IAI) is commonly associated with preterm birth and adverse neonatal sequelae. Early diagnosis of IAI, however, has been hindered by insensitive or nonspecific tests.

Objective  To identify unique protein signatures in rhesus monkeys with experimental IAI, a proteomics-based analysis of amniotic fluid was used to develop diagnostic biomarkers for subclinical IAI in amniotic fluid and blood of women with preterm labor.

Design, Setting, and Participants  Surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry, gel electrophoresis, and tandem mass spectrometry were used to characterize amniotic fluid peptides in 19 chronically instrumented pregnant rhesus monkeys before and after experimental IAI. Candidate biomarkers were determined by liquid chromatography–tandem mass spectrometry. Polyclonal antibodies were generated from synthetic peptides for validation of biomarkers of IAI. Amniotic fluid peptide profiles identified in experimental IAI were subsequently tested in a cohort of 33 women admitted to Seattle, Wash, hospitals between June 25, 1991, and June 30, 1997, with preterm delivery at 35 weeks or earlier associated with subclinical IAI (n = 11), preterm delivery at 35 weeks or earlier without IAI (n = 11), and preterm contractions with subsequent term delivery at later than 35 weeks (n = 11).

Main Outcome Measures  Identification of peptide biomarkers for occult IAI.

Results  Protein expression profiles in amniotic fluid showed unique signatures of overexpression of polypeptides in the 3- to 5-kDa and 10- to 12-kDa molecular weight ranges in all animals after infection and in no animal prior to infection. In women, the 10- to 12-kDa signature was identified in all 11 patients with subclinical IAI, in 2 of 11 with preterm delivery without IAI, and in 0 of 11 with preterm labor and term delivery without infection (P<.001). Peptide fragment analysis of the diagnostic peak in amniotic fluid identified calgranulin B and a unique fragment of insulinlike growth factor binding protein 1, which were also expressed in maternal serum. Mapping of other amniotic fluid proteins differentially expressed in IAI identified several immunoregulators not previously described in amniotic fluid.

Conclusions  This proteomics-based characterization of the differential expression of amniotic fluid proteins in IAI identified a distinct proteomic profile in an experimental primate chorioamnionitis model that detected subclinical IAI in a human cohort with preterm labor. These diagnostic protein expression signatures, complemented by immunodetection of specific biomarkers in amniotic fluid and in maternal serum, might have application in the early detection of IAI.


Author Affiliations: Division of Reproductive Sciences, Oregon National Primate Research Center, Beaverton, Ore (Drs Gravett and Novy); Departments of Obstetrics and Gynecology (Dr Gravett) and Pediatrics (Drs Rosenfeld, Roberts, and Nagalla) and Division of Biostatistics, Public Health and Preventive Medicine (Dr Lapidus), Oregon Health and Science University, and ProteoGenix Inc (Drs Reddy, Jacob, and McCormack and Mr Turner), Portland, Ore; Lucile Packard Foundation for Children's Health, Palo Alto, Calif (Dr Rosenfeld); Department of Obstetrics and Gynecology, University of Washington (Drs Hitti and Eschenbach), Seattle.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Shotgun Proteomic Analysis of Vaginal Fluid From Women in Late Pregnancy
Klein et al.
Reproductive Sciences 2008;15:263-273.
ABSTRACT  

Proteomics Analysis of Human Amniotic Fluid
Cho et al.
Mol. Cell. Proteomics 2007;6:1406-1415.
ABSTRACT | FULL TEXT  

Newer approaches to the diagnosis of early onset neonatal sepsis.
Mishra et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2006;91:F208-F212.
ABSTRACT | FULL TEXT  

Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
Pang et al.
Clin. Chem. 2006;52:421-429.
ABSTRACT | FULL TEXT  

An emerging role for comprehensive proteome analysis in human pregnancy research
Shankar et al.
Reproduction 2005;129:685-696.
ABSTRACT | FULL TEXT  

The Molecular Pathophysiology of Bacterially Induced Preterm Labor: Insights From the Murine Model
Hirsch and Wang
Reproductive Sciences 2005;12:145-155.
ABSTRACT  

Proteomic Profiling and Intra-amniotic Infection
Buhimschi et al.
JAMA 2004;292:2338-2338.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.